Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
Status:
Terminated
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficiency of pain relief and the safety of
NPC-06 for the neuropathic pain associated with cancer, in addition to explore the effective
concentration of NPC-06.